Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Safety
  4. Fast Track Articles
  5. Fast Track Article
image of Mycophenolate Mofetil Induced-Colitis: Is it More about Clinical Diagnosis?

Abstract

Background

Mycophenolate mofetil (MMF) is an immunosuppressant commonly used for treating autoimmune diseases.

Case Presentation

We report a diagnostically challenging case of MMF-induced colitis in a patient after 3 years of initiation of MMF therapy. A 76-year-old Caucasian female with a history of Chronic inflammatory demyelinating polyneuropathy receiving MMF presented to the hospital with a 7-weeks history of watery diarrhoea and crampy abdominal pains. Routine blood investigations, CMV-PCR, stool culture, viral PCR, Colonoscopy, and CT scan of the abdomen were broadly within normal limits. Histopathological changes were not significantly diagnostic apart from ischaemic-type changes. Finally, the reduction of the MMF dose caused the cessation of diarrhoea. Diagnosing MMF-induced colitis can be challenging, especially in patients on immunosuppressive medications. Further, long latency periods and non-specific colonoscopic and histopathologic changes add to the diagnostic dilemma.

Conclusion

MMF-induced diarrhoea should be part of the clinician’s differentials, and the decision to reduce the dose of MMF needs to be considered once infection and other causes have been ruled out.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863318109241104111738
2025-01-02
2025-01-27

  • From This Site

    /content/journals/cds/10.2174/0115748863318109241104111738
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Allison A.C. Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000 47 2-3 85 118 10.1016/S0162‑3109(00)00188‑0 10878285
    [Google Scholar]
  2. Calmet F.H. Yarur A.J. Pukazhendhi G. Ahmad J. Bhamidimarri K.R. Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation. Ann. Gastroenterol. 2015 28 3 366 373 26126799
    [Google Scholar]
  3. Maes BD Dalle I Geboes K Oellerich M Armstrong VW Evenepoel P Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation. 2003 75 5 665 72 10.1097/01.TP.0000053753.43268.F0
    [Google Scholar]
  4. Davies NM Grinyó J Heading R Maes B Meier-Kriesche HU Oellerich M Gastrointestinal side effects of mycophenolic acid in renal transplant patients: A reappraisal. Nephrol Dial Transplant. 2007 22 9 2440 8 10.1093/ndt/gfm308
    [Google Scholar]
  5. Lee F.D. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J. Clin. Pathol. 1993 46 2 118 122 10.1136/jcp.46.2.118 8459031
    [Google Scholar]
  6. de Andrade L.G.M. Rodrigues M.A.M. Romeiro F.G. Garcia P.D. Contti M.M. de Carvalho M.F.C. Clinicopathologic features and outcome of mycophenolate‐induced colitis in renal transplant recipients. Clin. Transplant. 2014 28 11 1244 1248 10.1111/ctr.12452 25142167
    [Google Scholar]
  7. Dhakal P. Gami R. Giri S. Bhatt V.R. Mofetil M. Mycophenolate Mofetil (MMF)-Induced Colitis. Blood 2016 128 22 4795 10.1182/blood.V128.22.4795.4795
    [Google Scholar]
  8. Selbst M.K. Ahrens W.A. Robert M.E. Friedman A. Proctor D.D. Jain D. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil. Mod. Pathol. 2009 22 6 737 743 10.1038/modpathol.2009.44 19329937
    [Google Scholar]
  9. Goyal A. Salahuddin M. Govil Y. A unique case of mycophenolate induced colitis after 10 years of use. Case Rep. Gastrointest. Med. 2016 2016 1 3 10.1155/2016/3058407 27668102
    [Google Scholar]
  10. Bandelier C. Guerne P-A. Genevay S. Finckh A. Gabay C. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med. Wkly. 2009 139 3-4 41 46 10.4414/smw.2009.12441 19169902
    [Google Scholar]
  11. Al Saadi W Al Salmi I Mohammed E Al Ajmi Z Hannawi S. Mycophenolate induced colitis: One-year post-kidney transplantation. Oman Med J. 2023 38 2 e489 10.5001/omj.2023.14
    [Google Scholar]
  12. Farooqi R Kamal A Burke C. Mycophenolate-induced colitis: A case report with focused review of literature. Cureus. 2020 12 1 e6774 10.7759/cureus.6774
    [Google Scholar]
  13. Moroncini G. Benfaremo D. Mandolesi A. Gabrielli A. Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis. BMJ Case Rep. 2018 2018 bcr-2018-224829 10.1136/bcr‑2018‑224829 29776943
    [Google Scholar]
  14. Srinivas TR Meier-Kriesche H-U Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result. Clin J Am Soc Nephrol. 2008 3 Suppl 2 S101 16 10.2215/CJN.03510807
    [Google Scholar]
  15. Bouhbouh S. Rookmaaker M.B. Rapid resolution of persistent mycophenolate mofetil-induced diarrhoea with a single dose of infliximab. Nephrol. Dial. Transplant. 2010 25 10 3437 3438 10.1093/ndt/gfq379 20615909
    [Google Scholar]
/content/journals/cds/10.2174/0115748863318109241104111738
Loading

  • Article Type:     Case Report
Keywords: diarrhoea ; Mycophenolate mofetil ; colitis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test